Proteomics for cancer drug design
Sign Up to like & getrecommendations! Published in 2019 at "Expert Review of Proteomics"
DOI: 10.1080/14789450.2019.1650025
Abstract: ABSTRACT Introduction: Signal transduction cascades drive cellular proliferation, apoptosis, immune, and survival pathways. Proteins have emerged as actionable drug targets because they are often dysregulated in cancer, due to underlying genetic mutations, or dysregulated signaling… read more here.
Keywords: protein; proteomic technologies; proteomics cancer; drug ... See more keywords